Trial intelligence / Profile preview

DRM02 in Rosacea

NCT01993446Phase 2Completed

Sponsor
Dermira, Inc.
Start
Oct 2013
Primary completion
Feb 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of drm02 in rosacea, sponsored by Dermira, Inc.. Started Oct 2013; status: completed.

02

Drugs

drm02
03

Conditions

rosacea

Beyond the preview

Go deeper on NCT01993446.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01993446.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call